DOCSLIB.ORG

National Antibiotic Guidelines 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Antibiotic Guidelines 2018 National Antibiotic Guidelines 2018 Department of Health Manila, Philippines Cover Design John Michael L. Roque Layout Design Adell R. Azuelo Lora Alaine D. Raymundo John Michael L. Roque All rights reserved 2018 National Antibiotic Guidelines Committee Pharmaceutical Division Department of Health Philippine Blood Center, Lung Center Compound, Quezon Avenue, Quezon City, 1100 ISBN - 978-621-95675-1-0 Any part of the book or its entirety may be reproduced or transmitted without any alteration, in any form or by any means, with permission from DOH provided it is not used for commercial purposes. TABLE OF CONTENTS Message ...................................................................................................................................... i Acknowledgments .................................................................................................................... ii Editorial Team .......................................................................................................................... iv Abbreviations and Acronyms .................................................................................................. v Introduction ............................................................................................................................... 1 Blood-Borne Infections and Other Systemic Syndromes .................................................... 8 Bone and Joint Infections - Pediatric ................................................................................... 32 Bone and Joint Infections - Adult ......................................................................................... 39 Cardiovascular Infections ...................................................................................................... 47 Central Nervous System Infections ...................................................................................... 62 Dental and Oral Infections ..................................................................................................... 71 Gastrointestinal and Other Intraabdominal Infections ....................................................... 78 Ocular Infections ..................................................................................................................... 93 Respiratory Tract Infections Upper Respiratory Tract Infections……………………………………………………..105 Lower Respiratory Tract Infections…………………………………………………….128 Skin and Soft Tissue Infections - Pediatric ........................................................................ 148 Skin and Soft Tissue Infections - Adult .............................................................................. 173 Surgical Prophylaxis ............................................................................................................ 194 Urinary Tract Infections ........................................................................................................ 206 National Health Programs Filiariasis (Selective Treatment) ……………………………………………………..……221 Leprosy………………………………………………………………………..…………….…223 Malaria…………………………………………………………….……………………………225 Schistosomiasis…………………………………………………………………………..….236 Sexually Transmitted Infections………………………………………………………..….238 Tuberculosis…………………………………………………………………………..………261 Republic of the Philippines Department of Health OFFICE OF THE SECRETARY MESSAGE The discovery of antibiotics, considered as “Miracle Drugs” in the 1920s revolutionized man’s ability to treat many infectious diseases and save countless lives. However, with their misuse, an increasing number of microorganisms are now resistant to them, thus the emergence of antimicrobial resistance. This public health threat intensifies the risk of falling into more severe and prolonged illness leading to increased mortality and health care costs. The Philippine Action Plan to Combat AMR: One Health Approach in 2015 has set a strategic direction towards preventing the spread and potential harm caused by AMR, unifying and linking all relevant sectors in the country, to strengthen the prudent use of antibiotics. The Department of Health created the National Antibiotic Guidelines Committee (NAGCom), a body composed of infectious disease experts and other relevant fields to develop the National Antibiotic Guidelines (NAG). The guidelines aim to strengthen our program implementation on the rational use of antimicrobials. This contains the therapeutic recommendations for the common infectious diseases in the community setting and hospitals that will supplement the knowledge of our physicians on optimizing antibiotic treatment. The NAG will help improve quality of care in the country, improve patient outcomes and lower health care costs. We all have a responsibility to protect our people from the threat of antimicrobial resistance. As we move to achieve the Philippine Health Agenda, let us harmonize our efforts in the pursuit of better health care system. Together, we can win the war against AMR! FRANCISCO T. DUQUE III, MD, MSc Secretary of Health i ACKNOWLEDGMENTS The participation and assistance of the following experts and reviewers of this document are gratefully acknowledged: Dr. Estrella B. Paje-Villar, former NAG Committee Chair Dr. Ivan Olegario, former editor Dr. Corazon I. Flores, former Director of the Pharmaceutical Division DOH offices: Disease Prevention and Control Bureau (DPCB) Epidemiology Bureau (EB) Food and Drug Administration (FDA) Health Facilities Development Bureau (HFDB) Development Partner: World Health Organization Professional Associations: Pediatric Infectious Disease Society of the Philippines (PIDSP) Pediatric Nephrology Society of the Philippines (PNSP) Philippine Academy of Family Physicians (PAFP) Philippine Academy of Ophthalmology (PAO) Philippine Academy of Pediatric Pulmonologists (PAPP) Philippine Coalition Against Tuberculosis (PhilCAT) Philippine College of Chest Physicians (PCCP) Philippine College of Physicians (PCP) Philippine College of Surgeons (PCS) Philippine Dental Association (PDA) Philippine Dermatological Society (PDS) Philippine Hospital Infection Control Society, Inc. (PHICS) Philippine Neurological Association (PNA) Philippine Obstetrical and Gynecological Society (POGS) Philippine Orthopedic Association (POA) Philippine Pediatric Society (PPS) Philippine Pharmacists Association, Inc. (PPhA) Philippine Society for Microbiology and Infectious Disease (PSMID) Philippine Society of Nephrology (PSN) Philippine Society of Newborn Medicine (PSNBM) Philippine Society of Otolaryngology Head and Neck Surgery (PSO-HNS) ii Philippine Society for Pediatric Gastroenterology, Hepatology and Nutrition (PSPGHAN) Philippine Society of Pediatric Surgeons (PSPS) Philippine Urological Association (PUA) Hospitals: Philippine Children’s Medical Center (PCMC) Research Institute for Tropical Medicine (RITM) San Lazaro Hospital (SLH) The Medical City (TMC) Universirty of the Philippines-Philippine General Hospital (UP-PGH) iii EDITORIAL TEAM National Antibiotic Guidelines Committee Chair MEDIADORA C. SANIEL, MD, MBA-H, FPCP Members CELIA C. CARLOS, MD, FPPS, FPIDSP, FPSMID CARMINA A. DELOS REYES, MD, FPPS, FPIDSP MARI ROSE A. DE LOS REYES, MD, FPCP BENILDA B. GALVEZ, MD, FPCCP MARY ANN D. LANSANG, MD, MMEDSC CECILIA C. MARAMBA-LAZARTE, MD, MSCID, MSCCT ROSALIND G. VIANZON, MD, MPH CYNTHIA S. FABREGAS, MD, DPCOM OLIVIA M. LIMUACO, RPh, PhD YOLANDA R. ROBLES, RPh, PhD VITO G. ROQUE, Jr. MD Antimicrobial Resistance Program Secretariat ANNA MELISSA M. GUERRERO, MD, MPH (HTA) IRENE V. FLORENTINO-FARIÑAS, RPH, MD, MNSA MS. ANNE JULIENNE M. GENUINO, RPH MS. NIÑA ISABELLE M. TOLENTINO, RPH MS. LORA ALAINE D. RAYMUNDO, RPH iv ABBREVIATIONS AND ACRONYMS ABECB Acute bacterial exacerbation of chronic bronchitis ABP Acute bacterial prostatitis ABRS Acute bacterial rhinosinusitis ABSSSI Acute bacterial skin and skin structure infections AL Artemether-lumefantrine ALT Alanine aminotransferase AOM Acute otitis media ARSP Antimicrobial Resistance Surveillance Program ART Antiretroviral therapy AS Artesunate ASB Asymptomatic bacteriuria AUC Acute uncomplicated cystitis BMI Body mass index BUN Blood urea nitrogen CAMRSA Community-associated MRSA CAP Community-acquired pneumonia CBP Chronic bacterial prostatitis CHD Congenital heart disease CMV Cytomegalovirus CNS Central nervous system CRP C-reactive protein CRS Chronic rhinosinusitis CSF Cerebrospinal fluid CSOM Chronic suppurative otitis media CT Computed tomography CVC Central venous catheter CVS Cardiovascular system DAIR Debridement and retention of prosthesis DEC Diethylcarbamazine DFI Diabetic foot infections EIA Enzyme immunoassay ELISA Enzyme-linked immunosorbent assay ENT Ears, nose and throat EPTB Extra pulmonary tuberculosis ESBL Extended spectrum beta-lactamase ESR Erythrocyte sedimentation rate ETEC Entero-toxigenic Escherichia coli FDC Fixed dose combination FQ Fluoroquinolone FTA-ABS Fluorescent treponemal antibody absorption test GIT Gastro-intestinal tract GABHS Group A Beta-hemolytic Streptococci v GAS Group A Streptococcus GCSF Granulocyte colony stimulating factor GNB Gram-negative bacteria GUT Genitourinary tract HACEK Haemophilus sp., Aggregatibacter sp., Cardiobacterium hominis, Eikinella corrodens, and Kingella sp. HAI Hospital-associated infections HAP Hospital-acquired pneumonia HBIG Hepatitis B Immunoglobulin HBeAg Hepatitis B envelope antigen HBsAg Hepatitis B surface antigen HBV Hepatitis B virus HCV Hepatitis C virus HR Isoniazid + Rifampicin HRZE/S Isoniazid + Rifampicin + Pyrazinamide + Ethambutol/Streptomycin
Load more

Recommended publications
  • Identification of Pasteurella Species and Morphologically Similar Organisms
    UK Standards for Microbiology Investigations Identification of Pasteurella species and Morphologically Similar Organisms Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 13 | Issue no: 3 | Issue date: 04.02.15 | Page: 1 of 28 © Crown copyright 2015 Identification of Pasteurella species and Morphologically Similar Organisms Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology – Identification | ID 13 | Issue no: 3 | Issue date: 04.02.15 | Page: 2 of 28 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Pasteurella species and Morphologically Similar Organisms Contents ACKNOWLEDGMENTS .........................................................................................................
    [Show full text]
  • Antibiotic Use Guidelines for Companion Animal Practice (2Nd Edition) Iii
    ii Antibiotic Use Guidelines for Companion Animal Practice (2nd edition) iii Antibiotic Use Guidelines for Companion Animal Practice, 2nd edition Publisher: Companion Animal Group, Danish Veterinary Association, Peter Bangs Vej 30, 2000 Frederiksberg Authors of the guidelines: Lisbeth Rem Jessen (University of Copenhagen) Peter Damborg (University of Copenhagen) Anette Spohr (Evidensia Faxe Animal Hospital) Sandra Goericke-Pesch (University of Veterinary Medicine, Hannover) Rebecca Langhorn (University of Copenhagen) Geoffrey Houser (University of Copenhagen) Jakob Willesen (University of Copenhagen) Mette Schjærff (University of Copenhagen) Thomas Eriksen (University of Copenhagen) Tina Møller Sørensen (University of Copenhagen) Vibeke Frøkjær Jensen (DTU-VET) Flemming Obling (Greve) Luca Guardabassi (University of Copenhagen) Reproduction of extracts from these guidelines is only permitted in accordance with the agreement between the Ministry of Education and Copy-Dan. Danish copyright law restricts all other use without written permission of the publisher. Exception is granted for short excerpts for review purposes. iv Foreword The first edition of the Antibiotic Use Guidelines for Companion Animal Practice was published in autumn of 2012. The aim of the guidelines was to prevent increased antibiotic resistance. A questionnaire circulated to Danish veterinarians in 2015 (Jessen et al., DVT 10, 2016) indicated that the guidelines were well received, and particularly that active users had followed the recommendations. Despite a positive reception and the results of this survey, the actual quantity of antibiotics used is probably a better indicator of the effect of the first guidelines. Chapter two of these updated guidelines therefore details the pattern of developments in antibiotic use, as reported in DANMAP 2016 (www.danmap.org).
    [Show full text]
  • Phenotypic and Molecular Characterization of the Capsular Serotypes of Pasteurella Multocida Isolates from Pneumonic Cases of Cattle in Ethiopia
    Phenotypic and Molecular Characterization of the Capsular Serotypes of Pasteurella multocida Isolates from Pneumonic Cases of Cattle in Ethiopia Mirtneh Akalu Yilma ( [email protected] ) Koneru Lakshmaiah Education Foundation https://orcid.org/0000-0001-5936-6873 Murthy Bhadra Vemulapati Koneru Lakshmaiah Education Foundation Takele Abayneh Tefera Veterinaerinstituttet Martha Yami VeterinaryInstitute Teferi Degefa Negi VeterinaryInstitue Alebachew Belay VeterinaryInstitute Getaw Derese VeterinaryInstitute Esayas Gelaye Leykun Veterinaerinstituttet Research article Keywords: Biovar, Capsular type, Cattle, Ethiopia, Pasteurella multocida Posted Date: January 19th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-61749/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/13 Abstract Background: Pasteurella multocida is a heterogeneous species and opportunistic pathogen associated with pneumonia in cattle. Losses due to pneumonia and associated expenses are estimated to be higher in Ethiopia with limited information about the distribution of capsular serotypes. Hence, this study was designed to determine the phenotypic and capsular serotypes of P. multocida from pneumonic cases of cattle. Methods: A cross sectional study with purposive sampling method was employed in 400 cattle from April 2018 to January 2019. Nasopharyngeal swabs and lung tissue samples were collected from clinically suspected pneumonic cases of calves (n = 170) and adult cattle (n = 230). Samples were analyzed using bacteriological and molecular assay. Results: Bacteriological analysis revealed isolation of 61 (15.25%) P. multocida subspecies multocida. Incidence was higher in calves 35 (57.38%) compared to adult cattle 26 (42.62%) at P < 0.5. PCR assay targeting KMT1 gene (~460 bp) conrmed P.
    [Show full text]
  • Swedres-Svarm 2019
    2019 SWEDRES|SVARM Sales of antibiotics and occurrence of antibiotic resistance in Sweden 2 SWEDRES |SVARM 2019 A report on Swedish Antibiotic Sales and Resistance in Human Medicine (Swedres) and Swedish Veterinary Antibiotic Resistance Monitoring (Svarm) Published by: Public Health Agency of Sweden and National Veterinary Institute Editors: Olov Aspevall and Vendela Wiener, Public Health Agency of Sweden Oskar Nilsson and Märit Pringle, National Veterinary Institute Addresses: The Public Health Agency of Sweden Solna. SE-171 82 Solna, Sweden Östersund. Box 505, SE-831 26 Östersund, Sweden Phone: +46 (0) 10 205 20 00 Fax: +46 (0) 8 32 83 30 E-mail: [email protected] www.folkhalsomyndigheten.se National Veterinary Institute SE-751 89 Uppsala, Sweden Phone: +46 (0) 18 67 40 00 Fax: +46 (0) 18 30 91 62 E-mail: [email protected] www.sva.se Text, tables and figures may be cited and reprinted only with reference to this report. Images, photographs and illustrations are protected by copyright. Suggested citation: Swedres-Svarm 2019. Sales of antibiotics and occurrence of resistance in Sweden. Solna/Uppsala ISSN1650-6332 ISSN 1650-6332 Article no. 19088 This title and previous Swedres and Svarm reports are available for downloading at www.folkhalsomyndigheten.se/ Scan the QR code to open Swedres-Svarm 2019 as a pdf in publicerat-material/ or at www.sva.se/swedres-svarm/ your mobile device, for reading and sharing. Use the camera in you’re mobile device or download a free Layout: Dsign Grafisk Form, Helen Eriksson AB QR code reader such as i-nigma in the App Store for Apple Print: Taberg Media Group, Taberg 2020 devices or in Google Play.
    [Show full text]
  • INFECTIOUS DISEASES of HAITI Free
    INFECTIOUS DISEASES OF HAITI Free. Promotional use only - not for resale. Infectious Diseases of Haiti - 2010 edition Infectious Diseases of Haiti - 2010 edition Copyright © 2010 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-090-4 ISBN-10: 1-61755-090-6 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. © 2010 GIDEON Informatics, Inc. www.gideononline.com All Rights Reserved. Page 2 of 314 Free. Promotional use only - not for resale. Infectious Diseases of Haiti - 2010 edition Introduction: The GIDEON e-book series Infectious Diseases of Haiti is one in a series of GIDEON ebooks which summarize the status of individual infectious diseases, in every country of the world.
    [Show full text]
  • Appendix a Bacteria
    Appendix A Complete list of 594 pathogens identified in canines categorized by the following taxonomical groups: bacteria, ectoparasites, fungi, helminths, protozoa, rickettsia and viruses. Pathogens categorized as zoonotic/sapronotic/anthroponotic have been bolded; sapronoses are specifically denoted by a ❖. If the dog is involved in transmission, maintenance or detection of the pathogen it has been further underlined. Of these, if the pathogen is reported in dogs in Canada (Tier 1) it has been denoted by an *. If the pathogen is reported in Canada but canine-specific reports are lacking (Tier 2) it is marked with a C (see also Appendix C). Finally, if the pathogen has the potential to occur in Canada (Tier 3) it is marked by a D (see also Appendix D). Bacteria Brachyspira canis Enterococcus casseliflavus Acholeplasma laidlawii Brachyspira intermedia Enterococcus faecalis C Acinetobacter baumannii Brachyspira pilosicoli C Enterococcus faecium* Actinobacillus Brachyspira pulli Enterococcus gallinarum C C Brevibacterium spp. Enterococcus hirae actinomycetemcomitans D Actinobacillus lignieresii Brucella abortus Enterococcus malodoratus Actinomyces bovis Brucella canis* Enterococcus spp.* Actinomyces bowdenii Brucella suis Erysipelothrix rhusiopathiae C Actinomyces canis Burkholderia mallei Erysipelothrix tonsillarum Actinomyces catuli Burkholderia pseudomallei❖ serovar 7 Actinomyces coleocanis Campylobacter coli* Escherichia coli (EHEC, EPEC, Actinomyces hordeovulneris Campylobacter gracilis AIEC, UPEC, NTEC, Actinomyces hyovaginalis Campylobacter
    [Show full text]
  • HL7 Implementation Guide for CDA Release 2: NHSN Healthcare Associated Infection (HAI) Reports, Release 2 (U.S
    CDAR2L3_IG_HAIRPT_R2_D2_2009FEB HL7 Implementation Guide for CDA Release 2: NHSN Healthcare Associated Infection (HAI) Reports, Release 2 (U.S. Realm) Draft Standard for Trial Use February 2009 © 2009 Health Level Seven, Inc. Ann Arbor, MI All rights reserved HL7 Implementation Guide for CDA R2 NHSN HAI Reports Page 1 Draft Standard for Trial Use Release 2 February 2009 © 2009 Health Level Seven, Inc. All rights reserved. Co-Editor: Marla Albitz Contractor to CDC, Lockheed Martin [email protected] Co-Editor/Co-Chair: Liora Alschuler Alschuler Associates, LLC [email protected] Co-Chair: Calvin Beebe Mayo Clinic [email protected] Co-Chair: Keith W. Boone GE Healthcare [email protected] Co-Editor/Co-Chair: Robert H. Dolin, M.D. Semantically Yours, LLC [email protected] Co-Editor Jonathan Edwards CDC [email protected] Co-Editor Pavla Frazier RN, MSN, MBA Contractor to CDC, Frazier Consulting [email protected] Co-Editor: Sundak Ganesan, M.D. SAIC Consultant to CDC/NCPHI [email protected] Co-Editor: Rick Geimer Alschuler Associates, LLC [email protected] Co-Editor: Gay Giannone M.S.N., R.N. Alschuler Associates LLC [email protected] Co-Editor Austin Kreisler Consultant to CDC/NCPHI [email protected] Primary Editor: Kate Hamilton Alschuler Associates, LLC [email protected] Primary Editor: Brett Marquard Alschuler Associates, LLC [email protected] Co-Editor: Daniel Pollock, M.D. CDC [email protected] HL7 Implementation Guide for CDA R2 NHSN HAI Reports Page 2 Draft Standard for Trial Use Release 2 February 2009 © 2009 Health Level Seven, Inc. All rights reserved. Acknowledgments This DSTU was produced and developed in conjunction with the Division of Healthcare Quality Promotion, National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), and Centers for Disease Control and Prevention (CDC).
    [Show full text]
  • Phenotypic and Molecular Characterization of the Capsular Serotypes of Pasteurella Multocida Isolates from Bovine Respiratory Disease Cases in Ethiopia
    Phenotypic and Molecular Characterization of the Capsular Serotypes of Pasteurella Multocida Isolates From Bovine Respiratory Disease Cases in Ethiopia Mirtneh Akalu Yilma ( [email protected] ) Koneru Lakshmaiah Education Foundation https://orcid.org/0000-0001-5936-6873 Murthy Bhadra Vemulapati Koneru Lakshmaiah Education Foundation Takele Abayneh Tefera Veterinaerinstituttet Martha Yami VeterinaryInstitute Teferi Degefa Negi VeterinaryInstitue Alebachew Belay VeterinaryInstitute Getaw Derese VeterinaryInstitute Esayas Gelaye Leykun Veterinaerinstituttet Research article Keywords: Antibiogram, Biovar, Capsular type, Cattle, Ethiopia, Pasteurella multocida Posted Date: September 9th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-61749/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/15 Abstract Background: Pasteurella multocida is a heterogeneous species and opportunistic pathogen that causes bovine respiratory disease. This disease is one of an economically important disease in Ethiopia. Losses due to mortality and associated expenses are estimated to be higher in the country. Studies revealed that limited information is available regarding the capsular types, genotypes, and antimicrobial sensitivity of P. multocida isolates circulating in the country. This suggests, further molecular advances to understand the etiological diversity of the pathogens representing severe threats to the cattle population. Results: Bacteriological analysis of nasopharyngeal swab and pneumonic lung tissue samples collected from a total of 400 samples revealed isolation of 61 (15.25%) P. multocida subspecies multocida. 35 (20.59%) were isolated from calves and 26 (11.30%) from adult cattle. Molecular analysis using PCR assay targeting KMT1 gene (~460 bp) amplication was shown in all presumptive isolates. Capsular typing also conrmed the presence of serogroup A (hyaD-hyaC) gene (~1044 bp) and serogroup D (dcbF) gene (~657 bp) from 56 (91.80%) and 5 (8.20%) isolates, respectively.
    [Show full text]
  • APUTS) Reporting Terminology and Codes Microbiology (V1.0
    AUSTRALIAN PATHOLOGY UNITS AND TERMINOLOGY (APUTS) Reporting Terminology and Codes Microbiology (v1.0) 1 12/02/2013 APUTS Report Information Model - Urine Microbiology Page 1 of 1 Specimen Type Specimen Macro Time Glucose Bilirubin Ketones Specific Gravity pH Chemistry Protein Urobilinogen Nitrites Haemoglobin Leucocyte Esterases White blood cell count Red blood cells Cells Epithelial cells Bacteria Microscopy Parasites Microorganisms Yeasts Casts Crystals Other elements Antibacterial Activity No growth Mixed growth Urine MCS No significant growth Klebsiella sp. Bacteria ESBL Klebsiella pneumoniae Identification Virus Fungi Growth of >10^8 org/L 10^7 to 10^8 organism/L of mixed Range or number Colony Count growth of 3 organisms 19090-0 Culture Organism 1 630-4 LOINC >10^8 organisms/L LOINC Significant growth e.g. Ampicillin 18864-9 LOINC Antibiotics Susceptibility Method Released/suppressed None Organism 2 Organism 3 Organism 4 None Consistent with UTI Probable contamination Growth unlikely to be significant Comment Please submit a repeat specimen for testing if clinically indicated Catheter comments Sterile pyuria Notification to infection control and public health departments PUTS Urine Microbiology Information Model v1.mmap - 12/02/2013 - Mindjet 12/02/2013 APUTS Report Terminology and Codes - Microbiology - Urine Page 1 of 3 RCPA Pathology Units and Terminology Standardisation Project - Terminology for Reporting Pathology: Microbiology : Urine Microbiology Report v1 LOINC LOINC LOINC LOINC LOINC LOINC LOINC Urine Microbiology Report
    [Show full text]
  • Evaluation of Different API Systems for Identification of Porcine Pasteurella Multocida Isolates
    ARTICLE IN PRESS Available online at www.sciencedirect.com Research in Veterinary Science xxx (2008) xxx–xxx www.elsevier.com/locate/rvsc Evaluation of different API systems for identification of porcine Pasteurella multocida isolates Y.A. Vera Lizarazo, E.F. Rodrı´guez Ferri, C.B. Gutie´rrez Martı´n * Department of Animal Health, Section of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Leo´n, 24007 Leo´n, Spain Accepted 5 February 2008 Abstract An exhaustive biochemical characterisation of 60 porcine Pasteurella multocida clinical isolates recovered from lesions indicative of pneumonia, previously confirmed by PCR and all belonging to the capsular serogroup A, was performed by means of four commercial systems. The API 20NE correctly identified almost all isolates (95%), but only 60% could be ascribed to this species by the API 20E method. The high diversity exhibited by the API 50CHB/E system, with six different patterns, does not advise its use as additional system for a definitive identification at the species level, but this method could be a potential tool for characterising P. multocida isolates below this level. The more uniform reactions yielded by the API ZYM test make this system helpful in the confirmatory identification of this organism. The high variability (20 profiles) obtained when the four systems are taken together also suggests their usefulness for epide- miological purposes in order to sub-type P. multocida isolates. Ó 2008 Elsevier Ltd. All rights reserved. Keywords: Pasteurella multocida; Swine; Biochemical characterisation; Identification Although Pasteurella multocida is part of the commensal In this study, we report an exhaustive biochemical char- flora of the upper respiratory tract of swine, it may induce acterisation of P.
    [Show full text]
  • Infectious Diseases of the Dominican Republic
    INFECTIOUS DISEASES OF THE DOMINICAN REPUBLIC Stephen Berger, MD 2018 Edition Infectious Diseases of the Dominican Republic Copyright Infectious Diseases of the Dominican Republic - 2018 edition Stephen Berger, MD Copyright © 2018 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN: 978-1-4988-1759-2 Visit www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. Scope of Content Disease designations may reflect a specific pathogen (ie, Adenovirus infection), generic pathology (Pneumonia - bacterial) or etiologic grouping (Coltiviruses - Old world). Such classification reflects the clinical approach to disease allocation in the Infectious Diseases Module of the GIDEON web application.
    [Show full text]
  • Infectious Diseases of the Horse
    INFECTIOUS DISEASES of the Diagnosis, pathology, HORSE management, and public health J. H. van der Kolk DVM, PhD, dipl ECEIM Department of Equine Sciences–Medicine Faculty of Veterinary Medicine Utrecht University, the Netherlands E. J. B. Veldhuis Kroeze DVM, dipl ECVP Department of Pathobiology Faculty of Veterinary Medicine Utrecht University, the Netherlands MANSON PUBLISHING / THE VETERINARY PRESS Copyright © 2013 Manson Publishing Ltd ISBN: 978-1-84076-165-8 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the written permission of the copyright holder or in accordance with the provisions of the Copyright Act 1956 (as amended), or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 33–34 Alfred Place, London WC1E 7DP, UK. Any person who does any unauthorized act in relation to this publication may be liable to criminal prosecution and civil claims for damages. A CIP catalogue record for this book is available from the British Library. For full details of all Manson Publishing Ltd titles please write to: Manson Publishing Ltd, 73 Corringham Road, London NW11 7DL, UK. Tel: +44(0)20 8905 5150 Fax: +44(0)20 8201 9233 Email: [email protected] Website: www.mansonpublishing.com Commissioning editor: Jill Northcott Project manager: Kate Nardoni Copy editor: Ruth Maxwell Layout: DiacriTech, Chennai, India Colour reproduction: Tenon & Polert Colour Scanning Ltd, Hong Kong Printed by: Grafos SA, Barcelona, Spain CONTENTS Introduction 5 Actinomyces spp. 90 Abbreviations 6 Dermatophilus congolensis: ‘rain scald’ or streptotrichosis 92 Chapter 1 Corynebacterium pseudotuberculosis: ‘pigeon fever’ 94 Bacterial diseases 9 Mycobacterium spp.: tuberculosis 97 Nocardia spp.
    [Show full text]